Effect of canagliflozin on endothelial function in patients with type 2 diabetes - Effect of canagliflozin on endothelial function in patients with type 2 diabetes

Medical Center for Translational and Clinical Research, Hiroshima University Hospital0 个研究点目标入组 6 人开始时间: 2016年12月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Has history of hypersensitivity to Canagliflozin 2. Has history of administration of SGLT2 inhibitor within 4 weeks before initiation of the study 3.patient with insulin dependent diabetes mellitus 4. Has history of myocardial infarction, angina, cerebral infarction, intracranial hemorrhage, subarachnoid hemorrhage, transient ischemic attacks within 3 months before initiation of the study 5. patient with ASO 6. With severe renal dysfunction (eGRF <45 mL/min or patient undergoing artificial dialysis) 7. Has history of severe ketosis, diabetic coma, or precoma within 6 months 8. Has history of cancer, severe infection 9. Pregnant, possibly pregnant, planned to become pregnant or nursing women 10. Are considered not eligible for the study by the attending doctor due to other reasons

发起方

Medical Center for Translational and Clinical Research, Hiroshima University Hospital